| 000 | 01759 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513185818.0 | ||
| 264 | 0 | _c19990823 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0027-8424 | ||
| 024 | 7 |
_a10.1073/pnas.96.15.8716 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMamoun, C B | |
| 245 | 0 | 0 |
_aA set of independent selectable markers for transfection of the human malaria parasite Plasmodium falciparum. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cJul 1999 |
||
| 300 |
_a8716-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAminohydrolases _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimalarials _xpharmacology |
| 650 | 0 | 4 |
_aAspergillus _xenzymology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aDNA Replication _xgenetics |
| 650 | 0 | 4 |
_aDNA Transposable Elements _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance _xgenetics |
| 650 | 0 | 4 | _aGene Dosage |
| 650 | 0 | 4 | _aGenetic Markers |
| 650 | 0 | 4 |
_aGentamicins _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKanamycin Kinase _xgenetics |
| 650 | 0 | 4 |
_aNucleosides _xpharmacology |
| 650 | 0 | 4 |
_aPlasmodium falciparum _xgenetics |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aGluzman, I Y | |
| 700 | 1 | _aGoyard, S | |
| 700 | 1 | _aBeverley, S M | |
| 700 | 1 | _aGoldberg, D E | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 96 _gno. 15 _gp. 8716-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.96.15.8716 _zAvailable from publisher's website |
| 999 |
_c10370035 _d10370035 |
||